These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 1080869

  • 1. [Mucous membrane specific protease inhibitors in bronchial mucus in severe chronic obstructive bronchitis and in alpha 1-antitrypsin deficiency syndrome].
    Rasche B, Hochstrasser K, Marcic I, Ulmer WT.
    Respiration; 1975; 32(5):340-54. PubMed ID: 1080869
    [Abstract] [Full Text] [Related]

  • 2. [Inhibitors of proteases in bronchial secretion of patients deficient in alpha-l-antitrypsin].
    Laine A, Lebas J, Hayem A.
    Lille Med; 1976 Feb; 21(2):140-3. PubMed ID: 1084948
    [No Abstract] [Full Text] [Related]

  • 3. [Concentration of low-molecular protease inhibitor in the bronchial secretion in 1 -antitrypsin deficiency].
    Reichert R, Hochstrasser K, Fruhmann G, Fritz H, Werle E.
    Pneumonologie; 1972 Feb; 147(1):41-5. PubMed ID: 5083260
    [No Abstract] [Full Text] [Related]

  • 4. [The role of granulocytic proteinases and their inhibitors in the pathogenesis of nonspecific endobronchitis (review)].
    Ogloblina OG.
    Vopr Med Khim; 1984 Feb; 30(1):3-13. PubMed ID: 6324487
    [Abstract] [Full Text] [Related]

  • 5. Effect of corticosteroids on sputum sol-phase protease inhibitors in chronic obstructive pulmonary disease.
    Wiggins J, Elliott JA, Stevenson RD, Stockley RA.
    Thorax; 1982 Sep; 37(9):652-6. PubMed ID: 6984237
    [Abstract] [Full Text] [Related]

  • 6. Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy.
    Cox DW, Hoeppner VH, Levison H.
    Am Rev Respir Dis; 1976 May; 113(5):601-6. PubMed ID: 1083700
    [Abstract] [Full Text] [Related]

  • 7. Elastase inhibitors of sputum sol phase: variability, relationship to neutrophil elastase inhibition, and effect of corticosteroid treatment.
    Stockley RA, Morrison HM, Kramps JA, Dijkman JH, Burnett D.
    Thorax; 1986 Jun; 41(6):442-7. PubMed ID: 2431494
    [Abstract] [Full Text] [Related]

  • 8. [The protease-inhibitor capacity of human bronchial mucus. Content in low molecular inhibitor and 1 -antitrypsin under physiological and physiopathological conditions].
    Reichert R, Hochstrasser K, Conradi G.
    Pneumonologie; 1972 Jun; 147(1):13-20. PubMed ID: 5083256
    [No Abstract] [Full Text] [Related]

  • 9. Alpha 1-antichymotrypsin in infected and noninfected sputum.
    Stockley RA, Burnett D.
    Am Rev Respir Dis; 1980 Jul; 122(1):81-8. PubMed ID: 6893262
    [Abstract] [Full Text] [Related]

  • 10. Elastase inhibitors in sputum from bronchitic patients with and without alpha 1-proteinase inhibitor deficiency: partial characterization of a hitherto unquantified inhibitor of neutrophil elastase.
    Morrison HM, Kramps JA, Afford SC, Burnett D, Dijkman JH, Stockley RA.
    Clin Sci (Lond); 1987 Jul; 73(1):19-28. PubMed ID: 2440636
    [Abstract] [Full Text] [Related]

  • 11. Protease inhibitors in chronic obstructive pulmonary disease.
    Barnett TB, Gottovi D, Johnson AM.
    Am Rev Respir Dis; 1975 May; 111(5):587-93. PubMed ID: 1079422
    [Abstract] [Full Text] [Related]

  • 12. Low molecular mass bronchial proteinase inhibitor and alpha 1-proteinase inhibitor in sputum and bronchoalveolar lavage.
    Stockley RA, Morrison HM, Smith S, Tetley T.
    Hoppe Seylers Z Physiol Chem; 1984 May; 365(5):587-95. PubMed ID: 6332053
    [Abstract] [Full Text] [Related]

  • 13. Proteinase inhibitors in rheumatoid arthritis.
    Brackertz D, Hagmann J, Kueppers F.
    Ann Rheum Dis; 1975 Jun; 34(3):225-30. PubMed ID: 1080403
    [Abstract] [Full Text] [Related]

  • 14. Variability in sputum sol phase proteins in chronic obstructive bronchitis. The value of using albumin for standardization.
    Wiggins J, Stockley RA.
    Am Rev Respir Dis; 1983 Jul; 128(1):60-4. PubMed ID: 6603183
    [Abstract] [Full Text] [Related]

  • 15. The biochemical pathogenesis of chronic obstructive pulmonary diseases: protease-antiprotease imbalance in emphysema and diseases of the airways.
    Kuhn C.
    J Thorac Imaging; 1986 Mar; 1(2):1-6. PubMed ID: 3298671
    [Abstract] [Full Text] [Related]

  • 16. Airways inflammation in chronic bronchitis: the effects of smoking and alpha1-antitrypsin deficiency.
    Hill AT, Bayley DL, Campbell EJ, Hill SL, Stockley RA.
    Eur Respir J; 2000 May; 15(5):886-90. PubMed ID: 10853853
    [Abstract] [Full Text] [Related]

  • 17. The mucosal defence capacity against proteolytic leukocyte enzymes.
    Tegner H, Fryksmark U, Ohlsson K.
    Eur J Respir Dis Suppl; 1985 May; 139():62-5. PubMed ID: 3876236
    [Abstract] [Full Text] [Related]

  • 18. [Proteolytic and antitrypsin activity of plasma in patients with bronchial asthma and chronic bronchitis with coexisting emphysema].
    Hofman J, Matusiewicz R.
    Pol Arch Med Wewn; 1973 Apr; 50(4):345-52. PubMed ID: 4702958
    [No Abstract] [Full Text] [Related]

  • 19. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.
    Sorrells S, Camprubi S, Griffin R, Chen J, Ayguasanosa J.
    Respir Med; 2015 Apr; 109(4):490-9. PubMed ID: 25727857
    [Abstract] [Full Text] [Related]

  • 20. [Changes in protease inhibitor balance of the bronchoalveolar secretion in children with inflammatory lung diseases].
    Bogadel'nikov IV, Kubyshkin AV, Gavalova NG.
    Pediatriia; 1990 Apr; (3):17-20. PubMed ID: 2385464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.